WPC-1108

GPTKB entity

Properties (63)
Predicate Object
gptkbp:instanceOf chemical compound
gptkbp:analyzes in progress
gptkbp:application used in drug formulation
gptkbp:campusFacilities gptkb:XYZ_University
gptkbp:chemicalFormula C12H16N2O2
amide
gptkbp:clinicalTrials gptkb:USA
Phase II
promising
gptkbp:collaborations gptkb:ABC_Pharmaceuticals
international
gptkbp:community_service overall survival
not identified
gptkbp:compatibleWith high
gptkbp:competitors high
WPC-1109
gptkbp:composedOf via acylation reaction
gptkbp:contraindication headache
gptkbp:dissolved soluble in water
gptkbp:dosageForm once daily
gptkbp:drugInterdiction studied
none known
under investigation
IND123456
gptkbp:endOfLife 4 hours
gptkbp:enrollment ongoing
adults
gptkbp:environmentalImpact low toxicity
gptkbp:exemplifies lactose
gptkbp:fauna mouse
gptkbp:formulation tablet
gptkbp:funding government grant
gptkbp:future_plans clinical trials
https://www.w3.org/2000/01/rdf-schema#label WPC-1108
gptkbp:iceClass 300 °C
150 °C
gptkbp:impact nausea
favorable
gptkbp:ingredients gptkb:WPC-1108
gptkbp:is_aimed_at cancer
gptkbp:isATypeOf 123456-78-9
gptkbp:market not yet approved
gptkbp:nutritionalValue liver
gptkbp:origin N-(4-(dimethylamino)phenyl)-2-hydroxy-2-(4-methylphenyl)acetamide
gptkbp:patentCitation US1234567A
gptkbp:patentExpiration 2030
gptkbp:publications Journal of Medicinal Chemistry
gptkbp:regulatoryCompliance gptkb:FDA
under review
gptkbp:related_to WPC-1107
gptkbp:releaseYear 2010
gptkbp:research NIH grant
gptkbp:research_areas oncology
medicinal chemistry
gptkbp:route oral
gptkbp:safety handle with care
gptkbp:safety_features acceptable
gptkbp:sponsor gptkb:XYZ_Pharmaceuticals
gptkbp:storage store in a cool, dry place
gptkbp:triggerType inhibits cell proliferation
gptkbp:uses pharmaceutical applications
gptkbp:waterManagement urine
gptkbp:weight 220.27 g/mol